Clinical Trial: Progression Suppression and Retinal Regression in VEGF-resistant AMD

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07005323) titled 'Progression Suppression and Retinal Regression in VEGF-resistant AMD' on March 03.

Brief Summary: The goal of this clinical trial is to assess safety and efficacy in patients with Neovascular Age-related Macular Degeneration with no response to existing therapy.

The main measures it aims to answer are:

* Investigation of adverse events

* Changes in clinical testing data

* Changes in vital signs

* Changes in intraocular pressure of the therapeutic eye

* Changes in testing of anterior segment of the therapeutic eye Participants will be implanted one sheet of PAL-222 into the subretinal space through pars plana vitrectomy.

Resear...